MD4177B1 - Method for vaccination against hepatitis B of persons with immunodeficiency - Google Patents
Method for vaccination against hepatitis B of persons with immunodeficiency Download PDFInfo
- Publication number
- MD4177B1 MD4177B1 MDA20110006A MD20110006A MD4177B1 MD 4177 B1 MD4177 B1 MD 4177B1 MD A20110006 A MDA20110006 A MD A20110006A MD 20110006 A MD20110006 A MD 20110006A MD 4177 B1 MD4177 B1 MD 4177B1
- Authority
- MD
- Moldova
- Prior art keywords
- bgr
- persons
- vaccine
- immunodeficiency
- vaccination
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000002255 vaccination Methods 0.000 title abstract 3
- 206010061598 Immunodeficiency Diseases 0.000 title abstract 2
- 208000029462 Immunodeficiency disease Diseases 0.000 title abstract 2
- 208000002672 hepatitis B Diseases 0.000 title abstract 2
- 230000007813 immunodeficiency Effects 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 abstract 1
- 229940124736 hepatitis-B vaccine Drugs 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 235000012054 meals Nutrition 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 229930002534 steroid glycoside Natural products 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20110006A MD4177C1 (ro) | 2011-01-14 | 2011-01-14 | Metodă de vaccinare contra hepatitei virale B a persoanelor imunocompromise |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20110006A MD4177C1 (ro) | 2011-01-14 | 2011-01-14 | Metodă de vaccinare contra hepatitei virale B a persoanelor imunocompromise |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD4177B1 true MD4177B1 (en) | 2012-07-31 |
| MD4177C1 MD4177C1 (ro) | 2013-02-28 |
Family
ID=46582439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20110006A MD4177C1 (ro) | 2011-01-14 | 2011-01-14 | Metodă de vaccinare contra hepatitei virale B a persoanelor imunocompromise |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD4177C1 (mo) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD667Z (ro) * | 2013-03-20 | 2014-03-31 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Metodă de tratament al mononucleozei infecţioase la copii |
| MD782Z (mo) * | 2013-07-16 | 2015-01-31 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Metodă de vaccinare contra gripei |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4189471A (en) * | 1978-07-11 | 1980-02-19 | Merck & Co., Inc. | Immunologic glycolipid adjuvants |
| SU1162817A1 (ru) * | 1983-07-06 | 1985-06-23 | Отдел Генетики Растений Ан Мсср | Способ выделени триозида @ (25 @ )-фурост-5-ен-3 @ ,22 @ ,26 триола @ -26-0- @ - @ -глюкопиранозида |
| US5583112A (en) * | 1987-05-29 | 1996-12-10 | Cambridge Biotech Corporation | Saponin-antigen conjugates and the use thereof |
| CA1331443C (en) * | 1987-05-29 | 1994-08-16 | Charlotte A. Kensil | Saponin adjuvant |
| CA2167537A1 (en) * | 1993-07-19 | 1995-02-02 | Tsuneo Ozeki | Hepatitis c virus proliferation inhibitor |
| RU2127605C1 (ru) * | 1996-05-22 | 1999-03-20 | Юрий Леонидович Криворутченко | Способ стимулирования гуморального и клеточного иммунного ответа на целевой антиген |
| MD1473G2 (ro) * | 1998-06-02 | 2001-05-31 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Remediu antiherpetic |
| US20060079492A1 (en) * | 1999-10-25 | 2006-04-13 | Ahlem Clarence N | Compositions and treatment methods |
| MD1875G2 (ro) * | 1999-11-01 | 2002-09-30 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Metodă de tratament al hepatitei virale acute B |
| US6905712B2 (en) * | 1999-12-08 | 2005-06-14 | Statens Veterinarmedicinska Anstalt | Vaccine adjuvants comprising ginseng plant extract and added aluminum salt |
| WO2001097749A2 (en) * | 2000-06-23 | 2001-12-27 | Kotze, Gavin, Salomon | The use of synthetic, non-hormonal 21-aminosteroids and thereof |
| MD2026G2 (ro) * | 2001-12-05 | 2003-05-31 | Институт Физиологии Растений Академии Наук Республики Молдова | Procedeu de sporire a rezistenţei plantelor de viţă de vie la secetă |
| MD3121G2 (ro) * | 2005-09-15 | 2007-03-31 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Metodă de profilaxie a hepatitei virale B |
| RU2311926C2 (ru) * | 2006-02-15 | 2007-12-10 | Федеральное Агентство По Образованию Государственное Образовательное Учреждение Высшего Профессионального Образования "Дальневосточный Государственный Университет" | Носитель и адъювант для антигенов |
| TWI393725B (zh) * | 2006-08-08 | 2013-04-21 | Henkan Pharmaceutical Co Ltd | 可預防及治療癌症之喃三醇配醣體化合物 |
| CZ300116B6 (cs) * | 2006-12-05 | 2009-02-11 | Zentiva, A. S. | Zpusob cištení hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu |
| US8802662B2 (en) * | 2009-06-16 | 2014-08-12 | Industrial Technology Research Institute | Anti-hepatitis C composition and method for preparing drug for inhibiting hepatitis C viruses or treating hepatitis C |
| TWI351280B (en) * | 2009-06-16 | 2011-11-01 | Ind Tech Res Inst | Anti-hepatitis c composition, method for preparing |
-
2011
- 2011-01-14 MD MDA20110006A patent/MD4177C1/ro not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD4177C1 (ro) | 2013-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ606993A (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
| HRP20192189T1 (hr) | Doziranja i terapijske primjene l-4-klorokinurenina | |
| WO2021205225A8 (en) | 25-hydroxyvitamin d for the treatment of sars-cov-2 infection | |
| Li et al. | Regulation of innate and adaptive immunity using herbal medicine: benefits for the COVID-19 vaccination | |
| Falsey et al. | Respiratory syncytial virus Prefusion F vaccine | |
| MD4177B1 (en) | Method for vaccination against hepatitis B of persons with immunodeficiency | |
| MX2013003523A (es) | Composicion farmaceutica de dosis baja. | |
| RU2017112748A (ru) | Композиции онапристона пролонгированного действия и способы | |
| Mateo-Casas et al. | Severe lymphopenia after subcutaneous cladribine in a patient with multiple sclerosis: To vaccinate or not? | |
| Gilbert et al. | Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults≥ 50 years | |
| JP5846624B2 (ja) | Ｈ５ｎ１型インフルエンザワクチン及び感染防御キット | |
| Kelen et al. | H1N1 vaccination in pediatric renal transplant patients | |
| MD3121F1 (en) | Method of viral hepatitis B prophylaxis | |
| Gambhir et al. | Intranasal (IN) COVID-19 vaccines-a breakthrough | |
| Chawla et al. | COVID-19 Therapy: Molecular Mechanisms, Pharmacological Interventions and Therapeutic Targets | |
| JP2009263384A (ja) | Ｉ型アレルギー性疾患のアトピー性皮膚炎の症状を抑制するための内服薬 | |
| RU2015140567A (ru) | Фармацевтические композиции на основе донепезила, характеризующиеся специфическим профилем растворимости in vitro или фармакокинетическими параметрами | |
| Saba et al. | A Comprehensive Therapeutic Landscape of COVID-19 | |
| AL IDRISSI et al. | Chloroquineand hydroxychloroquine in covid 19: asystematic review | |
| Kandhavelu et al. | Vaccines, Repurposed Drugs and Alternative Biomedicines for the Management and Prevention of COVID-19 | |
| JP2009263385A (ja) | Ｉ型アレルギー性疾患の鼻炎の症状を抑制するための内服薬 | |
| INFANTUM | pseudorubella, exanthem criticum, and three-day fever) is a generally mild clinical | |
| approves Fluzone | High-Dose influenza vaccine for the over 65s | |
| Meredith | Potassium iodide/spironolactone | |
| MD596Y (en) | Method for treating the chronic viral hepatitis C |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG4A | Patent for invention issued | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |